Renaissance Capital provides pre-IPO research to institutional investors and investment banks. The Firm manages two IPO-focused funds: The Renaissance IPO ETF (NYSE: IPO) and the Renaissance ...

Just a month after announcing a $115 million series D financing to advance its lead assets, Maze Therapeutics is looking to ...

For example, the success story of Zomato's IPO may be viewed in one context wherein ... The intricacy and uncertainty of IPOs entail research, timing, and sometimes even intuition.

AbCellera Biologics (ABCL) intends to raise $357 million in an IPO of its common stock ... According to a 2020 market research report by Grand View Research, the global market for research ...

The IPO (Initial Public Offering) of Sai Life Sciences Ltd (Sai Life), an emerging contract research, development and manufacturing organisation (CRDMO), is open for subscription at a critical ...

The Great Restaurant Development Holdings Limited (HPOT) has filed to raise $10 million in an IPO of its ordinary shares ... According to a 2024 market research report by China Daily, the Hong ...

InMed Pharmaceuticals (INM) has filed to raise $10 million from the sale of common stock and warrants in an uplisting / Nasdaq IPO, according ... to a 2019 market research report by Technavio ...

Contract research company Anthem Biosciences has filed ... The selling shareholders will be entitled to the proceeds from the IPO and the company will not receive any proceeds from the Offer.